TAGLN and neoplasm: While traditionally considered a marker of smooth muscle differentiation, recent studies have unveiled the involvement of TAGLN in cancer biology, particularly its upregulation in stromal cells within the tumor microenvironment and its correlation with poor prognosis in several cancers [39].